Congenital dyserythropoietic anemia, type 1, in a polynesian patient: Response to interferon α2b

Journal of Pediatric Hematology/Oncology

Volumn 24, Issue 6, 2002, Pages 503-506

  Roda, Laurent ^a   Pasche, Jérôme ^a   Fournier, Alain ^a   Terorotua, Vaea ^a   Wickramasinghe, Sunitha N ^a   Tamary, Hannah ^a   Schischmanoff, Pierre Olivier ^a   Tchernia, Gil ^a   Delaunay, Jean ^a  

^a BICÊTRE HOSPITAL   (France)

Author keywords

Congenital dyserythropoietic anemia, type 1; Hemoglobin level; Interferon 2b; Polynesia

Indexed keywords

ALPHA2B INTERFERON; HEMOGLOBIN;

ADOLESCENT; ARTICLE; BLOOD TRANSFUSION; BONE MARROW BIOPSY; CASE REPORT; FEMALE; GALLSTONE; HEMOGLOBIN DETERMINATION; HEREDITARY HEMOLYTIC ANEMIA; HUMAN; HUMAN CELL; IRON OVERLOAD; POLYNESIA; PRIORITY JOURNAL; RETICULOCYTE COUNT;

ANEMIA, DYSERYTHROPOIETIC, CONGENITAL; BLOOD TRANSFUSION; ERYTHROBLASTS; FEMALE; HEMOGLOBINS; HUMANS; INFANT; INFANT, NEWBORN; INTERFERON ALFA-2B; MALE; PEDIGREE; POLYNESIA; RETICULOCYTE COUNT;

EID: 0036693856     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200208000-00020     Document Type: Article

References (24)

1. Heimpel H, Wendt F. Congenital dyserythropoietic anemia with karyorrhexis and multinuclearity of erythroblasts. Helv Med Acta 1968;34:103-15.
2. Wickramasinghe SN. Congenital dyserythropoietic anemias: clinical features, hematological morphology and new biochemical data. Blood Rev 1998;12:178-200.
3. Delaunay J, Iolascon A. The congenital dyserythropoietic anemias. In: Anstee DJ, Tanner MJA, eds. Red cell membrane disorders. London: Baillière's Best Practice and Research in Clinical Hematology 1999;12:691-705.
4. Le Merrer M, Girot R, Parent P, et al. Acral dysostosis dyserythropoiesis syndrome. Eur J Pediatr 1995;154:384-8.
5. Shalev H, Tamary H, Shaft D, et al. Neonatal manifestations of congenital dyserythropoietic anemia type I. J Pediat 1997;131:95-97.
6. Shalev H, Moser A, Kapleushnik J, et al. Congenital dyserythropoietic anemia type I presenting as persistent pulmonary hypertension of the newborn. J Pediatr 2000;136:553-5.
7. Parez N, Dommergues M, Zupan V, et al. Severe congenital dyserythropoietic anemia type I: prenatal management, transfusion support and alpha-interferon therapy. Br J Haematol 2000;110:420-3.
8. Kato K, Sugitani M, Kawataki M, et al. Congenital dyserythropoietic anemia type I with fetal onset of severe anemia. J Pediat Hematol Oncol 2000;23:63-6.
9. Lavabre-Bertrand T, Blanc P, Navarro R, et al. Alpha-interferon therapy for congenital dyserythropoiesis type I. Br J Haematol 1995;89:929-32.
10. Virjee S, Hatton C. Congenital dyserythropoiesis type I and alpha-interferon therapy. Br J Haematol 1996;94:581-2.
11. Shamseddine A, Taher A, Jaafar H, et al. Interferon alpha is an effective therapy for congenital dyserythropoietic anemia type I. Eur J Haematol 2000;65:207-9.
12. Tamary H, Shalev H, Luria D, et al. Clinical features and studies of erythropoiesis in Israeli Bedouins with congenital dyserythropoietic anemia type I. Blood 1996;87:1763-70.
13. Tamary H, Shalmon L, Shalev H, et al. Localisation of the gene for congenital dyserythropoietic anemia to chromosome 15q15.1-15.3. Am J Hum Genet 1998;62:1062-9.
14. Alloisio N, Jaccoud P, Dorléac E, et al. Alterations of globin chain synthesis and of red cell membrane protein in congenital dyserythropoietic anemia I and II. Pediatr Res 1982;16:1016-21.
15. Hodges VV, Molloy GY, Wickramasinghe SN. Genetic heterogeneity of congenital dyserythropoietic anemia. Blood 1999;94:1139-40.
16. Rössler J, Heimpel H, Havers W. Diagnosis and clinical course of congenital dyserythropoietic anemia type I in a 12-year-old girl. Eur J Pediat 2001;160:139-40.
17. Alloisio N, Dalla Venezia N, Andrabi K, et al. Evidence that red cell protein p55 may participate in the skeleton-membrane linkage that involves protein 4.1 and glycophorin C. Blood 1993;82:1323-7.
18. Maeda K, Saeed SM, Rebuck JW, Monto RW. Type I dyserythropoietic anemia. A 30-year follow-up. Am J Clin Pathol 1980;73:433-8.
19. Choudhry VP, Saraya AK, Kasturi J, Rath PK. Congenital dyserythropoietic anemias: splenectomy as a mode of therapy. Acta Haematol 1981;66:195-201.
20. Tamary H, Shalev H, Pinsk V, et al. No response to recombinant human erythropoietin therapy in patients with congenital dyserythropoietic anemia type I. Pediatr Hematol Oncol 1999;16:165-8.
21. Lavabre-Bertrand T, Navarro M. Traitement de la dysérythropoièse congenitale de type I par l'interferon. Hématologie 1998;4:169.
22. Wickramasinghe SN. Response of CDA type I to alpha-interferon. Eur J Haematol 1997;58:121-3.
23. Wickramasinghe SN, Hasan R, Smythe J. Reduced interferon-alpha production by Epstein-Barr virus transformed B-lymphoblastoid cell lines and lectinstimulated lymphocytes in congenital dyserythropoietic anemia type I. Br J Haematol 1997;98:295-8.
24. Menike D, Wickramasinghe SN. Effects of four species of interferon-alpha on cultured erythroid progenitors from congenital dyserythropoietic anemia type I. Br J Haematol 1998;103:825-30.